fashion -WSS

fashion

author：focus 2025-09-30 18:17:19 - browse：1458

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Extreme heat events are a public health emergency

hotspot

WSS

More doctors should go into startup world

Diversify hospital leadership teams to protect BIPOC patient health

Just how powerful is the placebo effect?

Will General Catalyst be the first of many hospital takeovers?

More doctors should go into startup world

Removing probiotics from the NICU could threaten preemies' health

focus

fashion

explore

In Memoriam: Notable people who died in 2023

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The wait for US passports is creating travel purgatory and snarling summer plans

FDA approval of Sarepta Duchenne genetic therapy gives me hope

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Hepatitis C has a cure — but many Americans still lack access to it

Will General Catalyst be the first of many hospital takeovers?

Duchenne breakthrough therapy leaves behind pioneering families

Removing probiotics from the NICU could threaten preemies' health

Wikipedia

Being 'nonadherent' patient made me a more empathetic doctor

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Security flaws in third

Beware reading your test results before your doctor does

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

A letter from the executive editor: The 2023 STATUS List

hotspot

hotspot

knowledge

hotspot